Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

TICAGRELOR FOR SYSTEM SUITABILITY CRS (15 MG)

TICAGRELOR FOR SYSTEM SUITABILITY CRS (15 MG)

ND

DISCOVER
SORAFENIB TOSILATE CRS (120 MG)

SORAFENIB TOSILATE CRS (120 MG)

ND

DISCOVER
REGORAFENIB FOR FP SYSTEM SUITABILITY CRS (10 MG)

REGORAFENIB FOR FP SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
FORSYTHOSIDE A CRS (20 MG)

FORSYTHOSIDE A CRS (20 MG)

ND

DISCOVER
REGORAFENIB IMPURITY FP-B CRS(15 MG)

REGORAFENIB IMPURITY FP-B CRS(15 MG)

ND

DISCOVER
REGORAFENIB IMPURITY FP-C CRS(20 MG)

REGORAFENIB IMPURITY FP-C CRS(20 MG)

ND

DISCOVER
MORINDA ROOT FOR SYSTEM SUITABILITY HRS (520 MG)

MORINDA ROOT FOR SYSTEM SUITABILITY HRS (520 MG)

ND

DISCOVER
PREDNICARBATE FOR PEAK IDENTIFICATION CRS (15 MG)

PREDNICARBATE FOR PEAK IDENTIFICATION CRS (15 MG)

ND

DISCOVER
STREPTOMYCIN SULFATE FOR IDENTIFICATION CRS (25 MG)

STREPTOMYCIN SULFATE FOR IDENTIFICATION CRS (25 MG)

ND

DISCOVER
SORAFENIB IMPURITY H CRS (10 MG)

SORAFENIB IMPURITY H CRS (10 MG)

ND

DISCOVER
DEXPANTHENOL IMPURITY B CRS (15 MG)

DEXPANTHENOL IMPURITY B CRS (15 MG)

ND

DISCOVER
PIPERACILLIN FOR PEAK IDENTIFICATION CRS (15 MG)

PIPERACILLIN FOR PEAK IDENTIFICATION CRS (15 MG)

ND

DISCOVER